The Medical Disruptor exists for one reason: to give patients free access to clinicians who are brave enough to tell the truth. No products. No upsells. Just board-certified doctors who trained inside the system and eventually hit a wall it could not explain.

Dr. Ali Elahi is one of them. A neurologist with nearly two decades of conventional practice, he watched the same patients cycle through the same appointments, collect the same normal results, and leave with the same antidepressants while their brains quietly declined. In this episode, we dig into why memory loss and cognitive decline are routinely dismissed as depression or stress, how pharmaceutical money shapes what neurologists are taught, and why a clinically supported brain treatment called transcranial magnetic stimulation stays hidden from the patients who need it most. This is the conversation your neurologist was never trained to have with you.

What we cover: -Why early dementia is so often misdiagnosed as depression or anxiety -How pharmaceutical influence quietly shapes neurology training -What TMS is and what decades of evidence actually show -Why most TMS clinics are cutting corners and how to spot one that is not -The six questions every patient should ask before starting treatment -Why the window for early intervention matters more than most doctors admit.

Want more practical health tips? Join my newsletter! ⁠https://freechapter.lpages.co/newsletter-opt-in/⁠

Check us out on social media: ⁠

https://www.instagram.com/drefratlamandre⁠

⁠https://www.facebook.com/drefratlamandre⁠

⁠https://www.tiktok.com/@drefratlamandre⁠

#functionalmedicine #drefratlamandre #medicaldisruptor #NPwithaPHD #nursepractitioner #medicalgaslighting 

Chapters 

00:00 Introduction 

02:11 When guidelines stop working: frustration inside the system 

06:46 Why antidepressants work less than you think 

10:14 What is transcranial magnetic stimulation (TMS) 

13:23 How TMS works inside the brain without chemicals 

15:03 What TMS is currently FDA approved for 

19:44 The young onset dementia case published in clinical neurophysiology 

23:08 Why you have never heard of TMS (the marketing problem) 

36:21 What a proper TMS protocol actually looks like 49:13 What clinicians should read to get started 

53:57 What conditions TMS can treat

Guest Links: 

FB:https://www.facebook.com/neurospabrain/⁠ 

IG: ⁠https://www.instagram.com/neurospabrain/⁠ 

YT: ⁠https://www.youtube.com/@neurospabrain⁠ 

Website: ⁠https://www.youtube.com/@neurospabrain

Learn more about your ad choices. Visit megaphone.fm/adchoices